bendamustine hydrochloride has been researched along with Pemphigus Foliaceus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakawa, Y; Iwai, T; Kitamura, Y; Kuriyama, K; Matsumoto, Y; Nagata, H; Nishikawa, R; Ohshiro, M; Sugitani, M; Tsuji, T; Uchiyama, H | 1 |
| Abe, R; Amagai, M; Funakoshi, T; Kikuchi, T; Koda, Y; Kurihara, Y; Mori, T; Okamoto, S; Sato, H; Shimizu, T; Tsunoda, K; Yamagami, J | 1 |
| Cordes, SF; Liang, JJ; Witzig, TE | 1 |
| Abe, H; Asano, H; Fukayama, M; Higo, T; Kurokawa, M; Miyagaki, T; Nakamura, F; Senda, N; Shinohara, A; Yoshizaki, A | 1 |
4 other study(ies) available for bendamustine hydrochloride and Pemphigus Foliaceus
| Article | Year |
|---|---|
Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bendamustine Hydrochloride; Bronchiolitis Obliterans; Female; Humans; Lymphoma, Follicular; Paraneoplastic Syndromes; Pemphigus | 2022 |
Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.
Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Autoimmunity; Bendamustine Hydrochloride; Combined Modality Therapy; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunologic Factors; Lymphoma, Follicular; Neoplasm Grading; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Pemphigus; Radiodermatitis; Rituximab; Severity of Illness Index; Skin; Treatment Outcome; Tumor Burden | 2017 |
More than skin-deep.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Dexamethasone; Humans; Lymphoma, Non-Hodgkin; Male; Nail Diseases; Nitrogen Mustard Compounds; Oral Ulcer; Paraneoplastic Syndromes; Pemphigus; Rituximab; Weight Loss | 2013 |
Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Drug Eruptions; Female; Humans; Lymphoma, Follicular; Nitrogen Mustard Compounds; Paraneoplastic Syndromes; Pemphigus; Recurrence; Rituximab; Salvage Therapy | 2015 |